Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents

Flavonoids contain pharmacological effects that help to protect cells from damage. However, the anticancer activity of flavonoids is related to their modulation of signal transduction pathways within cancer cells. Natural substances such as flavonoids have immune-stimulating anti-tumor effect that c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammed Hadi Ali Al-Jumaili, Muqdad Khairi Yahya Al hdeethi
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/0a704c05382f47c7b01c725313612680
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0a704c05382f47c7b01c725313612680
record_format	dspace
spelling	oai:doaj.org-article:0a704c05382f47c7b01c7253136126802021-11-15T23:03:30ZStudy of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents1176-935110.1177/11769351211055160https://doaj.org/article/0a704c05382f47c7b01c7253136126802021-11-01T00:00:00Zhttps://doi.org/10.1177/11769351211055160https://doaj.org/toc/1176-9351Flavonoids contain pharmacological effects that help to protect cells from damage. However, the anticancer activity of flavonoids is related to their modulation of signal transduction pathways within cancer cells. Natural substances such as flavonoids have immune-stimulating anti-tumor effect that could lower breast cancer risk. However, various diseases included Alzheimer’s and cancer disease are associated with flavonoids intake due to their ability as antioxidant agent to alter essential cellular enzyme’s function. Therefore, through interaction between flavonoids and Cytochrome P450 (CYP) family enzymes led to make them chemopreventive agents for breast cancer. In this analysis, the chemo-informatics properties of 5 selective flavonoid derivatives and their efficiency as anti-breast cancer drugs were evaluated. Flavonoid ligands were docked with the predicted protein, which is human placental aromatase complexes with exemestane, a breast cancer drug (3S7S). Based on various docking energies, the molecular characteristics and bioactivity score of the following components, C 15 H 12 O 6 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one and C 15 H 12 O 5 5,8-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one showed greatest molecular properties and bioactivity docking scores of −8.633117 and −8.633117 kcal/mol respectively. Therefore, both compounds could be considered antitumor agent.Mohammed Hadi Ali Al-JumailiMuqdad Khairi Yahya Al hdeethiSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Informatics, Vol 20 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mohammed Hadi Ali Al-Jumaili Muqdad Khairi Yahya Al hdeethi Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
description	Flavonoids contain pharmacological effects that help to protect cells from damage. However, the anticancer activity of flavonoids is related to their modulation of signal transduction pathways within cancer cells. Natural substances such as flavonoids have immune-stimulating anti-tumor effect that could lower breast cancer risk. However, various diseases included Alzheimer’s and cancer disease are associated with flavonoids intake due to their ability as antioxidant agent to alter essential cellular enzyme’s function. Therefore, through interaction between flavonoids and Cytochrome P450 (CYP) family enzymes led to make them chemopreventive agents for breast cancer. In this analysis, the chemo-informatics properties of 5 selective flavonoid derivatives and their efficiency as anti-breast cancer drugs were evaluated. Flavonoid ligands were docked with the predicted protein, which is human placental aromatase complexes with exemestane, a breast cancer drug (3S7S). Based on various docking energies, the molecular characteristics and bioactivity score of the following components, C 15 H 12 O 6 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one and C 15 H 12 O 5 5,8-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one showed greatest molecular properties and bioactivity docking scores of −8.633117 and −8.633117 kcal/mol respectively. Therefore, both compounds could be considered antitumor agent.
format	article
author	Mohammed Hadi Ali Al-Jumaili Muqdad Khairi Yahya Al hdeethi
author_facet	Mohammed Hadi Ali Al-Jumaili Muqdad Khairi Yahya Al hdeethi
author_sort	Mohammed Hadi Ali Al-Jumaili
title	Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
title_short	Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
title_full	Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
title_fullStr	Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
title_full_unstemmed	Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
title_sort	study of selected flavonoid structures and their potential activity as breast anticancer agents
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/0a704c05382f47c7b01c725313612680
work_keys_str_mv	AT mohammedhadialialjumaili studyofselectedflavonoidstructuresandtheirpotentialactivityasbreastanticanceragents AT muqdadkhairiyahyaalhdeethi studyofselectedflavonoidstructuresandtheirpotentialactivityasbreastanticanceragents
_version_	1718426767181479936

Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents

Ejemplares similares